Morpho (MORPHO) is currently priced at $1.91, experiencing a 24-hour decline of 4.54%. The asset's daily range has been relatively tight, with a high of $2.03 and a low of $1.86, indicating a short-term downtrend.

Trading volume over the last 24 hours is approximately $26.78 million, with a volume-to-market cap ratio of 2.65%. The hourly moving averages are bearish, with the 8, 13, 21, and 55 SMAs all showing declines between 4.40% and 5.13%, which confirms a downward trend in the immediate term.

The 1-hour RSI is at a low 26, indicating that Morpho may be oversold in the short term, while the 7-day RSI stands at 47, suggesting a lack of momentum in either direction. The recent price changes reflect a 4.14% decline over the past week, a negligible 0.07% change over 14 days, but a positive 3.88% increase over 30 days, showing short-term weakness but medium-term stability.

The all-time high for Morpho is $4.17, reached in January 2025, suggesting significant room for upside potential if recovery occurs. However, the current price is nearly 54% below this level, emphasizing the need for a robust bullish reversal to regain investor confidence.

Given the recent technical indicators and bearish momentum, a short-term Sell rating is warranted. The negative price movement, combined with weak RSI levels and downward pressure from moving averages, suggests that traders should consider exiting positions until signs of recovery emerge.